Learn More
Medchemexpress LLC 6-bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl] | 1095382-05-0 | ≥98.0% | 551.48 g·mol⁻¹ | C26H31BrN8O | 5 MG

Supplier: Medchemexpress LLC HY108045MG
A potent, orally available Aurora kinase inhibitor active against Aurora A, B, and C that displays antiproliferative activity in multiple tumor cell lines. The compound is supplied as a powder for research use and has documented solubility and storage recommendations for both powder and solution forms.
- Potent inhibition of Aurora A, B, and C with IC50s of 15, 25, and 19 nM.
- Orally bioavailable compound showing antiproliferative activity in tumor cell lines.
- Supplied as a powder with high purity (≥98% by HPLC).
- Molecular weight 551.48 g·mol⁻¹ and formula C26H31BrN8O.
- Soluble in DMSO (16.67 mg/mL) and compatible with common vehicle formulations.
- Recommended storage: powder at -20°C (3 years) or 4°C (2 years); in solvent at -80°C (2 years).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.